FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309455301> ?p ?o ?g. }

• W4309455301 endingPage "1040" @default.
• W4309455301 startingPage "1040" @default.
• W4309455301 abstract "Lab-on-fiber (LoF) optrodes offer several advantages over conventional techniques for point-of-care platforms aimed at real-time and label-free detection of clinically relevant biomarkers. Moreover, the easy integration of LoF platforms in medical needles, catheters, and nano endoscopes offer unique potentials for in vivo biopsies and tumor microenvironment assessment. The main barrier to translating the vision close to reality is the need to further lower the final limit of detection of developed optrodes. For immune-biosensing purposes, the assay sensitivity significantly relies on the capability to correctly immobilize the capture antibody in terms of uniform coverage and correct orientation of the bioreceptor, especially when very low detection limits are requested as in the case of cancer diagnostics. Here, we investigated the possibility to improve the immobilization strategies through the use of hinge carbohydrates by involving homemade antibodies that demonstrated a significantly improved recognition of the antigen with ultra-low detection limits. In order to create an effective pipeline for the improvement of biofunctionalization protocols to be used in connection with LoF platforms, we first optimized the protocol using a microfluidic surface plasmon resonance (mSPR) device and then transferred the optimized strategy onto LoF platforms selected for the final validation. Here, we selected two different LoF platforms: a biolayer interferometry (BLI)-based device (commercially available) and a homemade advanced LoF biosensor based on optical fiber meta-tips (OFMTs). As a clinically relevant scenario, here we focused our attention on a promising serological biomarker, Cripto-1, for its ability to promote tumorigenesis in breast and liver cancer. Currently, Cripto-1 detection relies on laborious and time-consuming immunoassays. The reported results demonstrated that the proposed approach based on oriented antibody immobilization was able to significantly improve Cripto-1 detection with a 10-fold enhancement versus the random approach. More interestingly, by using the oriented antibody immobilization strategy, the OFMTs-based platform was able to reveal Cripto-1 at a concentration of 0.05 nM, exhibiting detection capabilities much higher (by a factor of 250) than those provided by the commercial LoF platform based on BLI and similar to the ones shown by the commercial and well-established bench-top mSPR Biacore 8K system. Therefore, our work opened new avenues into the development of high-sensitivity LoF biosensors for the detection of clinically relevant biomarkers in the sub-ng/mL range." @default.
• W4309455301 created "2022-11-28" @default.
• W4309455301 creator A5014128505 @default.
• W4309455301 creator A5014428484 @default.
• W4309455301 creator A5023271851 @default.
• W4309455301 creator A5025518286 @default.
• W4309455301 creator A5034818794 @default.
• W4309455301 creator A5037204722 @default.
• W4309455301 creator A5042858615 @default.
• W4309455301 creator A5066201657 @default.
• W4309455301 creator A5074325380 @default.
• W4309455301 creator A5088087663 @default.
• W4309455301 date "2022-11-17" @default.
• W4309455301 modified "2023-10-03" @default.
• W4309455301 title "Advanced Lab-on-Fiber Optrodes Assisted by Oriented Antibody Immobilization Strategy" @default.
• W4309455301 cites W1173063301 @default.
• W4309455301 cites W1827756911 @default.
• W4309455301 cites W1974979380 @default.
• W4309455301 cites W1988633531 @default.
• W4309455301 cites W1993336943 @default.
• W4309455301 cites W1995798426 @default.
• W4309455301 cites W2001670625 @default.
• W4309455301 cites W2022180924 @default.
• W4309455301 cites W2028709872 @default.
• W4309455301 cites W2029861082 @default.
• W4309455301 cites W2043733934 @default.
• W4309455301 cites W2045022183 @default.
• W4309455301 cites W2049273387 @default.
• W4309455301 cites W2067111286 @default.
• W4309455301 cites W2074653241 @default.
• W4309455301 cites W2075166860 @default.
• W4309455301 cites W2083936294 @default.
• W4309455301 cites W2099518877 @default.
• W4309455301 cites W2107834451 @default.
• W4309455301 cites W2115048638 @default.
• W4309455301 cites W2115619508 @default.
• W4309455301 cites W2146570831 @default.
• W4309455301 cites W2151220251 @default.
• W4309455301 cites W2161580535 @default.
• W4309455301 cites W2166400478 @default.
• W4309455301 cites W2166806803 @default.
• W4309455301 cites W2265560601 @default.
• W4309455301 cites W2273095871 @default.
• W4309455301 cites W2336841130 @default.
• W4309455301 cites W2399814375 @default.
• W4309455301 cites W2411375442 @default.
• W4309455301 cites W2464637858 @default.
• W4309455301 cites W2552225705 @default.
• W4309455301 cites W2555702089 @default.
• W4309455301 cites W2587359616 @default.
• W4309455301 cites W2595421984 @default.
• W4309455301 cites W2600986459 @default.
• W4309455301 cites W2765276428 @default.
• W4309455301 cites W2765854822 @default.
• W4309455301 cites W2803546469 @default.
• W4309455301 cites W2889423254 @default.
• W4309455301 cites W2890957363 @default.
• W4309455301 cites W2913042985 @default.
• W4309455301 cites W2918034985 @default.
• W4309455301 cites W2919784134 @default.
• W4309455301 cites W2922485383 @default.
• W4309455301 cites W3014484976 @default.
• W4309455301 cites W3021296873 @default.
• W4309455301 cites W3046902403 @default.
• W4309455301 cites W3048234996 @default.
• W4309455301 cites W3052092404 @default.
• W4309455301 cites W3083348469 @default.
• W4309455301 cites W310871636 @default.
• W4309455301 cites W3110657599 @default.
• W4309455301 cites W3117485415 @default.
• W4309455301 cites W3124596243 @default.
• W4309455301 cites W3131843789 @default.
• W4309455301 cites W3171060930 @default.
• W4309455301 cites W3195615736 @default.
• W4309455301 cites W3210650034 @default.
• W4309455301 cites W3216606278 @default.
• W4309455301 cites W4211105405 @default.
• W4309455301 cites W4286249431 @default.
• W4309455301 doi "https://doi.org/10.3390/bios12111040" @default.
• W4309455301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36421158" @default.
• W4309455301 hasPublicationYear "2022" @default.
• W4309455301 type Work @default.
• W4309455301 citedByCount "1" @default.
• W4309455301 crossrefType "journal-article" @default.
• W4309455301 hasAuthorship W4309455301A5014128505 @default.
• W4309455301 hasAuthorship W4309455301A5014428484 @default.
• W4309455301 hasAuthorship W4309455301A5023271851 @default.
• W4309455301 hasAuthorship W4309455301A5025518286 @default.
• W4309455301 hasAuthorship W4309455301A5034818794 @default.
• W4309455301 hasAuthorship W4309455301A5037204722 @default.
• W4309455301 hasAuthorship W4309455301A5042858615 @default.
• W4309455301 hasAuthorship W4309455301A5066201657 @default.
• W4309455301 hasAuthorship W4309455301A5074325380 @default.
• W4309455301 hasAuthorship W4309455301A5088087663 @default.
• W4309455301 hasBestOaLocation W43094553011 @default.
• W4309455301 hasConcept C106847996 @default.
• W4309455301 hasConcept C136229726 @default.
• W4309455301 hasConcept C155672457 @default.

• next